Skip to content

Clinical trials

Phase 2 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Phase: Phase 2 Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20081
20091
20101
20151
20161
20194
20202
20211
20221
20231
20255

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting3
Terminated3
Withdrawn3
Active, not recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Immunovant Sciences GmbH3
argenx2
Biogen1
Bioverativ, a Sanofi company1
Fred Hutchinson Cancer Center1
Istituto Clinico Humanitas1
Mamatha Pasnoor, MD1
MedDay Pharmaceuticals SA1
Nagoya University1
National Institute of Neurological Disorders and Stroke (NINDS)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating23
Autoimmune Diseases3
Autoimmune Diseases of the Nervous System1
Charcot-Marie-Tooth Disease1
Demyelinating Diseases1
Lambert-Eaton Myasthenic Syndrome1
Myasthenia Gravis1
Neuromyelitis Optica1
Opsoclonus-Myoclonus Syndrome1
Paraproteinemias1

Trials

Showing 26 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.